Amon Et Sanderson 2017 - What Is The Microbiome
Amon Et Sanderson 2017 - What Is The Microbiome
Amon Et Sanderson 2017 - What Is The Microbiome
com
Education & Practice Online First, published on February 28, 2017 as 10.1136/archdischild-2016-311643
RESEARCH IN PRACTICE
Research in practice
Figure 1 The human microbiome plays an important role in control of vital homeostatic mechanisms in the body. These include
enhanced metabolism, resistance to infection and inflammation, prevention against autoimmunity as well as an effect on the gut–
brain axis. SCFA, short-chain fatty acid.
conditions seen in paediatrics that have been asso- is thought to play a crucial role. Studies in both
ciated with changes in the gut microbiota (table 1).8– humans and animal models have described changes in
16
the gut microbiota including a reduction in bacterial
Inflammatory bowel disease (IBD)—This is one of diversity and increased abundances of Proteobacteria
the most extensively studied human conditions asso- in preterm infants with NEC compared with healthy
ciated with the gut microbiota. The composition of preterm infants.20 However, the results have been
the gut microbiota differs between healthy individuals inconsistent across studies, and to date, no single
and patients with IBD both in terms of species rich- causative set of microorganisms has been identified.
ness (ie, numbers of bacterial species) and species Atopic diseases—Conditions such as eczema, asthma
abundances (ie, number of individuals per species). As and food allergies are increasing in incidence. This is
bacteria are identified by sequencing, rather than by often linked to the hygiene hypothesis. It is thought
functional characteristics in the culture laboratory, the that the lack of early-life exposure to microbial anti-
individual bacterial species or genus (depending on gens in hygienic developed countries alters the micro-
the classification of sequence data) are commonly biota composition of the infant gut, which disrupts
referred to as operational taxonomic units in micro- immune development causing allergic disease.21 For
biota research. example, species like Bacteroides fragilis reportedly
Studies have reported patients with IBD to have induces immunological tolerance through immune
decreased bacterial diversity, and reduced abundances receptor signalling pathways.22 Also the infant gut
of Firmicutes and Bacteroidetes and an increased microbiota is affected by environmental factors
abundance of Proteobacteria compared with healthy including pets, residing in rural homes and siblings
individuals.17 Latest research suggests that IBD patho- shown to have protective effects against asthma and
genesis is due to the interaction of environmental allergies.23 The concept that altered microbiome
factors (eg, smoking, diet and stress) and the host’s composition influences childhood allergic disease sus-
genetic susceptibility, which is influenced by com- ceptibility is further supported by data from epi-
mensal microbiota, which activates either pathogenic demiological studies that report higher prevalence of
or protective immune responses.18 Evidence from atopic diseases in infants delivered by caesarean sec-
mouse models provides further support for the role of tions, formula fed infants and those exposed to
gut microbiota in pathogenesis of IBD.19 antibiotics.24
Necrotising enterocolitis (NEC)—The pathogenesis Type 1 diabetes—The gut microbiota is involved in
of NEC is multifactorial although the gut microbiota regulation of the metabolic–immune axis.8 Research
Research in practice
Table 1 Alterations in gut microbiota exert an influence on organ systems in the body leading to disease
Organ Examples of diseases linked with altered microbiota Microbiota-mediated changes References
9, 25
Brain Autism spectrum disorder Abundance of bacterial toxins
Disrupted fermentation
11, 12, 21, 23, 24
Lung Asthma Reduced immunological tolerance
Cystic fibrosis Altered gene expression
13
Heart Cardiovascular disease Production of proinflammatory metabolites
8
Pancreas Type 1 and type 2 diabetes Reduced insulin sensitivity
10
Liver Non-alcoholic fatty liver disease Altered bile acid metabolism
8, 14, 15
Adipose tissue Metabolic syndrome Reduced intestinal gluconeogenesis
Obesity Insulin resistance
17–20, 22
Gastrointestinal tract Inflammatory bowel syndrome Dysregulated immune response
Irritable bowel syndrome Altered mucosal barrier
Gut infections
16
Skin Acne Increased pathogenic strains
Eczema Dysregulated immune response
Allergic diseases
studies speculating the specific causative microbial Contributors PA wrote the manuscript and IS reviewed and
composition and function have not been consistent. provided critical comments.
However, Bifidobacteria is believed to be protective, Competing interests None declared.
while Proteobacteria is a reported risk factor. Patient consent Obtained.
Similarly, changes in gut microbiota caused by lifestyle Provenance and peer review Commissioned; externally peer
(eg, mode of delivery and diet) are known risk factors reviewed.
for the development of type 1 diabetes, like birth by Open Access This is an Open Access article distributed in
accordance with the terms of the Creative Commons
caesarean section reportedly increases the risk of Attribution (CC BY 4.0) license, which permits others to
developing type 1 diabetes by 20%.7 distribute, remix, adapt and build upon this work, for
Autistic spectrum disorder (ASD)—The gut micro- commercial use, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0/
biota can influence human behaviour by modulating
the gut–brain axis via endocrine (cortisol), immune
(cytokines) and neural (vagus and enteric nervous
system) signalling pathways. Several studies have REFERENCES
described an altered gut microbiota in children with 1 Schroeder BO, Bäckhed F. Signals from the gut microbiota to
distant organs in physiology and disease. Nat Med
ASD compared with developmentally normal chil-
2016;22:1079–89.
dren.25 However, more work is needed to establish if
2 Moon Y. Microbiome-linked crosstalk in the gastrointestinal
this is important in the pathogenesis of the condition. exposome towards host health and disease. Pediatr
Gastroenterol Hepatol Nutr 2016;19:221–8.
3 Qin J, Li R, Raes J, et al. A human gut microbial gene
FUTURE POTENTIAL OF MICROBIOTA
catalogue established by metagenomic sequencing. Nature
MANIPULATION FOR THE TREATMENT OF
2010;464:59–65.
DISEASE 4 Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity,
Manipulation of the microbiota as a therapeutic tool stability and resilience of the human gut microbiota. Nature
is a rapidly advancing field in microbiome research. 2012;489:220–30.
There is an abundance of data suggesting treatments 5 Palmer C, Bik EM, DiGiulio DB, et al. Development of the
capable of reversing dysbiosis are effective in man- human infant intestinal microbiota. PLoS Biology 2007;5:
aging certain human diseases. Targeted antibiotic use e177.
to eliminate select microbiota, probiotics and prebio- 6 Meropol SB, Edwards A. Development of the infant intestinal
tics to encourage the expansion of beneficial bacteria microbiome: a bird’s eye view of a complex process. Birth
Defects Res C Embryo Today 2015;105:228–39.
and faecal microbiota transplantation to restore bac-
7 Charbonneau MR, Blanton LV, DiGiulio DB, et al. A microbial
terial communities are some of the approaches that
perspective of human developmental biology. Nature
are currently under investigation or in use. These 2016;535:48–55.
studies will provide a greater understanding of the 8 Sanz Y, Olivares M, Moya-Pérez Á, et al. Understanding the
host–microbiome interactions that impact on disease. role of gut microbiome in metabolic disease risk. Pediatr Res
As paediatricians, we need to keep abreast of the 2015; 77:236–44.
research as within the next decade, it is highly likely 9 Smith PA. The tantalizing links between gut microbes and the
that we may be using such treatments in our practice. brain. Nature 2015;526:312–14.
Research in practice
10 Betrapally NS, Gillevet PM, Bajaj JS. Changes in the 18 Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s
intestinal microbiome and alcoholic and nonalcoholic liver disease and ulcerative colitis. Nat Clin Pract Gastroenterol
diseases: causes or effects? Gastroenterology Hepatol 2006;3:390–407.
2016;150:1745–1755.e3. 19 Gkouskou KK, Deligianni C, Tsatsanis C, et al. The gut
11 Lynch SV. The lung Microbiome and airway disease. Ann Am microbiota in mouse models of inflammatory bowel disease.
Thorac Soc 2016;13(Suppl 5):S462–5. Front Cell Infect Microbiol 2014;4:28.
12 Kravchenko VV, Kaufmann GF, Mathison JC, et al. Modulation 20 Grishin A, Papillon S, Bell B, et al. The role of the intestinal
of gene expression via disruption of NF-κB signaling by a microbiota in the pathogenesis of necrotizing enterocolitis.
bacterial small molecule. Science 2008;321:259–63. Semin Pediatr Surg 2013;22:69–75.
13 Yamashita T, Emoto T, Sasaki N, et al. Gut microbiota and 21 Wold AE. The hygiene hypothesis revised: is the rising
coronary artery disease. Int Heart J 2016;57:663–71. frequency of allergy due to changes in the intestinal flora?
14 Herrema H, IJzerman RG, Nieuwdorp M. Emerging role of Allergy 1998;53:20–5.
intestinal microbiota and microbial metabolites in metabolic 22 Round JL, Lee SM, Li J, et al. The Toll-like receptor 2 pathway
control. Diabetologia 2016. establishes colonization by a commensal of the human
15 Ahmed I, Roy BC, Khan SA, et al. Microbiome, Metabolome microbiota. Science 2011;332:974–7.
and Inflammatory Bowel Disease. Microorganisms 2016;4:E20. 23 Ege MJ, Mayer M, Normand AC, et al. Exposure to
16 Kong HH, Andersson B, Clavel T, et al. Performing skin environmental microorganisms and childhood asthma. N Engl
microbiome research: a method to the madness. J Invest J Med 2011;364:701–9.
Dermatol 2017. 24 Riiser A. The human microbiome, asthma, and allergy. Allergy
17 Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced Asthma Clin Immunol 2015;11:35.
diversity of faecal microbiota in Crohn’s disease revealed by a 25 Ding HT, Taur Y, Walkup JT. Gut Microbiota and Autism: Key
metagenomic approach. Gut 2006;55:205–11. Concepts and Findings. J Autism Dev Disord 2016.
Arch Dis Child Educ Pract Ed published online February 28, 2017
These include:
References This article cites 22 articles, 3 of which you can access for free at:
http://ep.bmj.com/content/early/2017/02/28/archdischild-2016-311643
#BIBL
Open Access This is an Open Access article distributed in accordance with the terms of
the Creative Commons Attribution (CC BY 4.0) license, which permits
others to distribute, remix, adapt and build upon this work, for commercial
use, provided the original work is properly cited. See:
http://creativecommons.org/licenses/by/4.0/
Email alerting Receive free email alerts when new articles cite this article. Sign up in the
service box at the top right corner of the online article.
Notes